Endava (NYSE:DAVA) Price Target Raised to $20.00 at Needham & Company LLC

Endava (NYSE:DAVAGet Free Report) had its price target increased by investment analysts at Needham & Company LLC from $18.00 to $20.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Needham & Company LLC’s target price would indicate a potential upside of 20.16% from the stock’s current price.

Other equities research analysts have also recently issued research reports about the stock. Guggenheim lowered their price objective on shares of Endava from $40.00 to $28.00 and set a “buy” rating for the company in a research report on Tuesday, May 13th. Cowen lowered shares of Endava from a “buy” rating to a “hold” rating in a report on Wednesday, May 14th. Susquehanna dropped their target price on Endava from $50.00 to $42.00 and set a “positive” rating for the company in a research report on Tuesday, May 20th. TD Cowen lowered Endava from a “buy” rating to a “hold” rating and set a $17.00 price target on the stock. in a research note on Thursday, May 15th. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $18.00 price target on shares of Endava in a report on Monday, May 19th. Six equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, Endava has an average rating of “Hold” and a consensus price target of $27.00.

Get Our Latest Research Report on DAVA

Endava Stock Performance

Shares of NYSE:DAVA opened at $16.64 on Tuesday. Endava has a twelve month low of $14.00 and a twelve month high of $34.94. The firm has a market cap of $982.51 million, a PE ratio of 151.31, a price-to-earnings-growth ratio of 2.26 and a beta of 1.15. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.90 and a current ratio of 1.90. The business has a fifty day moving average of $17.20 and a 200-day moving average of $24.46.

Institutional Investors Weigh In On Endava

A number of institutional investors and hedge funds have recently added to or reduced their stakes in DAVA. Blue Trust Inc. boosted its holdings in Endava by 28.5% during the fourth quarter. Blue Trust Inc. now owns 1,494 shares of the company’s stock worth $46,000 after buying an additional 331 shares during the last quarter. State of New Jersey Common Pension Fund D boosted its stake in Endava by 22.8% during the 4th quarter. State of New Jersey Common Pension Fund D now owns 81,662 shares of the company’s stock worth $2,523,000 after acquiring an additional 15,173 shares during the last quarter. Kornitzer Capital Management Inc. KS boosted its stake in Endava by 2.8% during the 4th quarter. Kornitzer Capital Management Inc. KS now owns 287,510 shares of the company’s stock worth $8,884,000 after acquiring an additional 7,945 shares during the last quarter. Paradice Investment Management LLC grew its holdings in Endava by 24.3% during the fourth quarter. Paradice Investment Management LLC now owns 931,024 shares of the company’s stock valued at $28,769,000 after purchasing an additional 181,868 shares during the period. Finally, New York State Common Retirement Fund bought a new stake in Endava in the fourth quarter valued at approximately $442,000. Institutional investors own 62.23% of the company’s stock.

Endava Company Profile

(Get Free Report)

Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.

See Also

Analyst Recommendations for Endava (NYSE:DAVA)

Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.